PhasTIPP— 510(k) K212894

Substantially Equivalent

LeMaitre Vascular, Inc.

FDA 510(k) clearance K212894 for PhasTIPP, Substantially Equivalent on 2022-03-31. Applicant: LeMaitre Vascular, Inc..

Clearance details

Applicant: LeMaitre Vascular, Inc.
Product code: Code DWQ
Advisory panel: Cardiovascular
Date received: 2021-09-10
Decision date: 2022-03-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Burlington, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.